Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
How In-Home Trials Can Shift The Pediatric Rare Disease Research Landscape
DCT solutions are not just about bringing the trial to the patient’s home and reducing logistical burdens, but also strengthening the family-researcher connection.
Where Precision Drives Progress: Meeting The Rising Complexity Of Modern Clinical Trials
Discover how leading teams are using trusted data and targeted AI to design, plan, and execute clinical trials with the confidence today's science requires.
Gene, Cell, And RNA Therapy Landscape Continues To Thrive
The horizons of molecular medicine continued to expand in the Q4 2024, with pre-registration gene therapy programs up 83% from the third quarter.

Addressing Trial Design Hurdles Across Alzheimer's Disease Stages
12/10/2025

Explore how endpoint selection, rater training, and the strategic implementation of eCOA can help address the unique scientific, operational, and human considerations at each stage of AD.
Combining Multiple Challenge Models Within A Single Individual
10/8/2026

Pairing immune challenges in healthy volunteers tests whether pharmacology is consistent across cells, tissue, and systemic responses before patient trials.
On The GO: Inside The World Of Clinical Trial Travel Coordination (USA)
11/19/2024

Clinical trial Concierge Coordinators provide personalized support, addressing travel, logistics, and unique challenges for participants and caregivers, ensuring engagement, and trial success.
Korio RTSM Platform: Dosing Configuration Demo
3/16/2026

Protocols evolve — and Korio is built to evolve with them. In this demo, see how users can easily add new doses, configure dose use rules, and define logic for dose adjustments based on visit history or other criteria.
Delivering An Early-Phase Autoimmune Trial Across Regions
11/6/2026

Why do autoimmune trials stall when patients already have working treatments? See how one rare rheumatology study adapted its strategy to keep early-phase enrollment moving.

What Does 'Powered By Block Clinical' Mean?

Join us in supporting every part of the clinical trial ecosystem — patients, caregivers, sites, and suppliers — to ensure trials run safely, efficiently, and successfully.
Central Nervous System Drug Development

CNS drug development faces unique hurdles — from high placebo response to complex protocols and recruitment challenges. Discover strategies to streamline trials, optimize planning, and accelerate delivery of innovative therapies for patients with critical unmet needs.
Recruitment Strategies: A Behind The Scenes Look

Explore a dynamic recruitment strategy being used to address the growing demand for participants in early-stage clinical trials while overcoming regulatory and ethical challenges.
Driving Successful In CNS And Neurology Trials

Second, only to Oncology, CNS, and Neurology clinical trials are incredibly complex and complicated to navigate.
Advancing Proof-Of-Concept Clinical Trials

Support proof-of-concept trials with integrated clinical and CRO capabilities spanning study design, site selection, patient recruitment, monitoring, and data delivery.